April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Clinical Validation of Visual Simulation for Pseudophakic Patients
Author Affiliations & Notes
  • Christina Schwarz
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Carmen Canovas
    AMO, Groningen, Netherlands
  • Silvestre Manzanera
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Pedro Prieto
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Kendra Hileman
    AMO, Santa Ana, CA
  • Robert Rosén
    AMO, Groningen, Netherlands
  • Patricia A Piers
    AMO, Groningen, Netherlands
  • Henk A Weeber
    AMO, Groningen, Netherlands
  • Pablo Artal
    Laboratorio de Optica, Universidad de Murcia, Murcia, Spain
  • Footnotes
    Commercial Relationships Christina Schwarz, AMO (F); Carmen Canovas, AMO (E); Silvestre Manzanera, AMO (F); Pedro Prieto, AMO (F); Kendra Hileman, AMO (E); Robert Rosén, AMO (E); Patricia Piers, AMO (E); Henk Weeber, AMO (E); Pablo Artal, AMO (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5971. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christina Schwarz, Carmen Canovas, Silvestre Manzanera, Pedro Prieto, Kendra Hileman, Robert Rosén, Patricia A Piers, Henk A Weeber, Pablo Artal; Clinical Validation of Visual Simulation for Pseudophakic Patients. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5971.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Adaptive optics vision simulators (AOVS) have been used to evaluate the impact of aberrations or phase profiles on vision. The purpose of this study is to compare the clinical visual outcomes measured in patients implanted with different IOL models to those obtained by visual simulation using the phase profiles generated by the same IOLs.


A binocular AOVS (Schwarz et al. Opt Lett. 2011) was used to induce the phase profile corresponding to five different IOL designs, 2 refractive and 3 diffractive. High contrast through focus visual acuity (VA) was measured with SLOAN letters in 5 subjects with a 3.5 mm physical pupil in white light. Measurements were performed binocularly for all designs, bilaterally inducing each profile. For each case, the results of the testing in the AOVS were compared to the clinical outcomes measured in pseudophakic patients implanted with the corresponding IOL models. Data from three different clinical trials are included in this comparison, where the IOLs studied correspond to the phase profiles induced in the AOVS. These studies included bilaterally implanted patients. In this way, it is possible to compare binocular measurements performed in the AOVS with clinical measurements of binocular visual performance. In all clinical trials, high contrast through focus VA was measured between 1 and 3 months postoperatively with an ETDRS chart using trial lenses with a best distance correction in place, according to common clinical practice.


The average through focus VA measured in clinical studies is highly correlated with that measured in the AOVS for the IOL models evaluated. The figure below shows the through focus VA measured in both, the AOVS and the clinical trial for two of the IOL designs. The cross correlation coefficient between visual simulation and clinical data ranged from 0.960 to 0.994.


AOVS predicts clinical visual outcomes following cataract surgery under binocular conditions for the different IOL designs tested. These results validate the use of AOVS as a tool for developing new IOL optics.

Keywords: 434 binocular vision/stereopsis • 754 visual acuity • 653 presbyopia  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.